Table 2. Sirolimus Treatment.
Characteristics | N (%) |
---|---|
Indication for voriconazole | |
IFI Prophylaxis | 61 (91) |
IFI prophylaxis in setting of GVHD | 6 (9) |
Day of voriconazole initiation (day, range) | 8 (2-27) |
Duration of coadministration, days (days, range) | 113 (4-1342) |
0-100 days | 43 (64) |
100-200 days | 16 (24) |
200-300 days | 6 (9) |
300-1000 days | 1 (1) |
>1000 days | 1 (1) |
Concomitant tacrolimus administration | 67 (100) |